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Abstract
Left censoring is generally a rare type of censoring in time-to-event data, however
there are some fields such as HIV related studies where it commonly occurs. Cur-
rently, there is no clear recommendation in the literature on the optimal model and
distribution to analyze left-censored data. Recommendations can help researchers
apply more accurate models for this type of censoring. This study derives the Para-
metric Reversed Hazards (PRH) Model for a variety of distributions which may be
appropriate for left censored data. The performance of these derived PRH models to
analyze HIV viral load data are compared using extensive simulations and a guide-
line is established for which distribution/s are most appropriate. Each simulation
setup is varied by sample size and proportion of censoring to find a consistently high
performance distribution. The best distribution is determined using the information
criteria: AIC, AICC, HQIC, and CAIC. The South Carolina Enhanced HIV/AIDS
Reporting Surveillance System (SC eHARS) data were utilized and a bootstrap study
provided further insights towards appropriateness of the distributions in analyzing
HIV viral load data. Results from simulation studies point to the Generalized In-
verse Weibull distribution to outperform all others across censoring rates and sample
sizes. The bootstrap study, however, contradicts this and suggests the Marshal-Olkin
distribution to be the superior performer. This disagreement may have resulted from
the special heavy tail nature of viral load data that demands further attention. Appli-
cation of the best performing models on the SC eHARS database revealed important
effects explaining trends of viral load over time.
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Chapter 1
Introduction
1.1 Background
Analysis of survival data is used in various fields such as social science (event his-
tory), economics (duration analysis), engineering (reliability analysis), and medicine
(survival analysis). For consistency, we will refer to this type of analysis as survival
analysis, although techniques mentioned here can be applied in any field. Survival
analysis focuses on measuring time to event data, for example, time to death or time
to recovery. One of the issues with survival analysis is censoring. This occurs when
the time to the event of interest is not available for all subjects in the study due to
loss of follow-up, the event does not occur within the study period, or death occurs
from reasons not related to the research. There are three types of censoring; right
censoring, interval censoring, and left censoring. Right censoring is when the event
of interest is not observed in the study period, for example, if the subject drops out
before the end of the study. Interval censoring is when we know the event of interest
occurs in a certain time interval but the exact time of occurrence is unknown. This
commonly occurs in medical research and epidemiological studies with periodic mon-
itoring. Left censoring is when the event of interest has occurred before enrollment
into the study, but it is not known exactly when. For example, consider that the
event is the age at which children are able to learn the alphabet at school. There
may be some children who are able to recite the alphabet before starting school, these
subjects are left censored. Compared to the other types of censoring, left censoring
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less frequently occurs. As a result, it is often overlooked and understudied. In this
study, we focus on survival data which have left censored observations.
It is important to differentiate between censoring and truncation. When data is
truncated, there is a cut point beyond which observations cannot occur. For example,
age is naturally truncated since it cannot take on values less than zero. When data is
censored, the censored observations take on a range of values as they are only known
to be equal to or more extreme than a certain point. With respect to modeling,
censoring requires making probability calculations on a wide range of values whereas
truncation requires making probability calculations after rescaling the distribution to
reflect the truncated data.
If censoring is ignored when analyzing data, it can lead to underestimation of
the survival probability or mean, and inconsistent covariate effects.1 Additionally,
the impact of ignoring censoring increases as the proportion of censored observations
increases.2 The most frequently used approaches to deal with censoring is to replace
the censored value with an arbitrary value such as the detection limit value or half
of the limit value.3,4 This arbitrary replacement method usually results in overesti-
mation because the predicted values based on the arbitrary value would be higher
than the predicted values based on the unknown true values. These approaches also
underestimate the variability in the data because the same value is imputed several
times. Another potential approach developed by Paxton et al.5 is a two-stage im-
putation procedure which is used to predict the censored values by first substituting
half of the lower detection limit and then refitting the model by imputing the new
estimated values. This method is a slight improvement from the arbitrary replace-
ment methods since it removes much of the bias in the parameter estimates, but the
effect on the variability is less predictable.5 There is one major disadvantage to utiliz-
ing these convenient techniques: they ignore the correlated structure of longitudinal
data and do not adjust for the variability of the parameter estimates due to the loss
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of information from censoring. Ganser and Hewett6 developed a more sophisticated
substitution method they termed the β-substitution method which calculates a β
factor depending on the uncensored data and replaces the limit of detection with the
β factor multiplied by the limit of detection. This approach has been shown to be
less biased than the simpler substitution methods.6
An alternative to crude imputation methods is a maximum likelihood (ML) ap-
proach in which the censored data is incorporated into the log-likelihood functions of
the observed data.7,8 Although censored data lack information on the event of inter-
est, incorporating them in this way can provide valuable information to the model.
Hughes7 modified the usual mixed effects model by using a likelihood-based Monte
Carlo Expectation-Maximization (MCEM) algorithm to account for censoring. This
method removes the bias in the parameter estimates and the within-person variability
but there is some bias in the between-person variability which is mostly due to the
variability in the ML estimates of the uncensored data.7 Jacqmin-Gadda et al.8 used
a general likelihood with cumulative distribution function (CDF) to account for left-
censored observations. The formulation of the likelihood is conditioned on observed
measures and the marginal likelihood is used to make inferences about the unknown
parameters. The approach by Lyles, Lyles, and Taylor9 is based on a hierarchical
formulation of the likelihood where the estimation is carried out by direct maximiza-
tion of the likelihood. These likelihood approaches correct for the bias obtained when
an arbitrary value is assigned to the censored data.7–9 One disadvantage is it makes
stringent Gaussian distribution assumptions and is not easy to implement in standard
software.10
Traditional regression models are not able to handle censored data directly, and as
a result a wide class of non-parametric, semi-parametric and parametric survival mod-
els have been developed to handle data with censored observations. These models all
explore the relationship between the hazard rate of a subject and several independent
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variables. The commonly used form of these models can be written as
λ(t) = λ0(t)exiβ
where λ0(t) is the baseline hazard function, xi is the set of covariates, and β are
parameters estimating covariate effects on hazard. This proportional hazards (PH)
model assumes that the survival curves for any two subjects have hazard functions
which are proportional over time, i.e., they have a relative constant hazard. This
assumption can be checked by confirming that the complementary log-log survival
curves for the two subjects are parallel.
In semi-parametric models, the regression coefficients are estimated leaving the
baseline hazard unspecified. For example, the Cox Proportional Hazards model11 in-
troduced the use of the partial-likelihood function to estimate the coefficients without
needing to characterize the baseline hazard rate. There are several studies which use
non-parametric methods to correct for left-censoring.12–15 An advantage of using this
type of method is that distributional assumptions about the baseline hazard do not
have to be made. However, this can also be disadvantageous.
In a parametric regression model, a particular shape or distribution is specified for
the baseline hazard rate. These models let the parameters of the assumed distribution
depend on the covariates. An advantage of using parametric regression models is
that they naturally smooth the data by assuming an underlying distribution so that
censoring has less effect on parameter estimates than for semi-parametric methods.
If the characterization of the underlying time-dependency is accurate, i.e., if someone
chooses the correct distribution, then parameter estimates are generally more precise
than estimates from semi-parametric models where the underlying time-dependency
is left unspecified. However, problems can arise if the incorrect parametric form is
selected.
Determining which distribution to assume in the presence of left censoring is dif-
ficult as the existing literature on this is scarce and inconsistent due to the lack of
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guidelines. Many studies assume specific underlying distributions based on guide-
lines for right censored data or the shape of the data being analyzed. Thompson,
Voit, and Scott16 compared different distributions recommended for right censored
data using probability plots to find which one best fits their left censored data, prior
to running survival models. Annan, Liu, and Zhang17 compared various estimators
for left censored data using simulation studies in which they assume the underly-
ing distribution is exponential. They selected the exponential distribution reasoning
that common distributions usually associated with left/right censored data such as
the normal, lognormal and gamma distribution all belong to the exponential family.
Pajek et al.18 simulated data from a log-normal distribution to compare various esti-
mators for left censored data on trace element concentrations since this distribution
was experimentally validated in a prior study.19 Another study by Luczynska et al.20
assumed a Normal distribution with no validation as to why this distribution was used
in the analyses. Some survival studies16,21–23 assumed a Weibull distribution for the
left censored data simply because it is commonly used in survival analysis, especially
in the field of medicine, and approximately fits the data. Gupta and Kundu24 pro-
posed a new family of distributions, the generalized exponential distribution, which
is very similar to the corresponding shape of a gamma or Weibull distribution. The
probability density function (pdf) is of the form:
f(x;α, λ) = αλ(1− e−λx)α−1e−λx
where α and λ are the shape and scale parameters, respectively. Since these distribu-
tions are often used for censored data in survival analysis, the generalized exponential
distribution is a possible alternative to use in survival models. Expanding on this,
Mitra and Kundu25 derived the maximum likelihood estimator for data with left
censored observations from a generalized exponential distribution:
αˆ(λ) = − n− r
rln(1− e−λx(r+1) +∑ni=r+1 ln(1− e−λx(i))
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1.2 Motivating Example
Human immunodeficiency virus (HIV) is a chronic disease which weakens the im-
mune system, leading to increased susceptibility to a wide range of infections and
some types of cancer. HIV RNA or viral load (VL) measures the number of actively
replicating HIV virus in a subject and is an important biomarker for HIV disease
progression.26 There is no cure for HIV, but the success of highly active antiretro-
viral therapy (ART) to suppress VL to undetectable levels for prolonged periods of
time has transformed HIV into a manageable chronic disease.26 Suppression of VL to
undetectable levels improves physical functioning, reduces opportunistic infections,
reduces HIV related mortality, and is associated with a substantial decrease in the
probability of transmitting HIV to others.27–29 By CDC guideline, VL is detectable
if > 200 copies/mL and undetectable if ≤ 200 copies/mL. Not only is suppressing
VL important on an individual level, it also has the potential to decrease HIV in-
cidence rates in a community because of reduced infectivity.29,30 Consequently, the
focus of care has shifted from survival to improving health outcomes among people
with HIV.26
The HIV endemic disproportionately impacts the Southern states in the US in
terms of the overall number of people living with HIV/AIDS (PLWHA), and survival
rates after HIV/AIDS diagnosis.31 South Carolina (SC), like many Southern states,
ranks high for poverty, unemployment, and low educational completion which are all
characteristics that may promote disease transmission. The number of PLWHA in
SC has increased from 12,089 in 2004 to 16,311 in 2014.32 Recent studies on retention
in HIV care found that a large proportion of PLWHA in SC failed to remain in
care on a regular basis.33,34 Given the HIV burden in SC and the need to focus on
retention in HIV care within the context of the National HIV/AIDS Strategy goals,
it is important to identify factors which suppress VL. Identifying these factors will
assist in developing targeted strategies to reduce the HIV burden in SC.
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To provide insight into the HIV endemic in SC, survival models of time to unde-
tectable levels of VL should be analyzed. These models can also be used to assess the
effect of various drugs on the VL. Some subjects may have undetectable VL at the
beginning of the study, in which case the first point at which they reach detectable
level will be the start of their observations. Thus, these subjects are not censored.
However, this dataset is complicated with many left censored subjects where the time
of infection, i.e., the exact time VL reaches detectable levels is unknown. Further-
more, the distribution of VL patterns from detectable to undetectable levels varies
from person to person so there is a need to establish a baseline distribution which
can be used when analyzing this data.
In the literature on HIV datasets with left censoring, the most common approach
is to use a PH model because of its relative simplicity.35–39 One study showed the
consistency and asymptotic normality for the maximum likelihood estimator of the
PH model for doubly censored HIV data, i.e., data with both left and right censoring
present.39 An advantage of using the PH model is the ability to fit survival models
without knowing (or assuming) the underlying distribution. However, as explained
above in section 1.1, if the distribution is known or an appropriate distribution can
be assumed, then the maximum likelihood estimates from a parametric model are
more accurate than this simple approach. One study used a log logistic Accelerated
Failure Time (AFT) model to estimate the effect of age on time to VL suppression.40
However, the use of AFT models is very rare in cases where the data are left cen-
sored. Parametric regression models are more commonly applied to HIV data with
left censoring present.23,41–43 Studies by Zaba et al.41 and Isingo et al.23 used a para-
metric regression model based on the Weibull distribution to assess survival after HIV
infection. The authors from these studies selected a Weibull distribution as it more
closely fit the data, but no results of this comparison was provided in either article.
More specifically considering studies measuring time to HIV VL suppression,
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Thiébaut et al.42 applied a lognormal survival model using a full parametric approach
to take into account the left censored HIV VL and CD4+ counts. The lognormal dis-
tribution was utilized in their study as suggested by Henderson, Diggle, and Dobson44
because the estimated lognormal survival distribution function was contained within
the 95% confidence interval of non-parametric Kaplan Meier estimate. The authors
did further sensitivity analysis by comparing the lognormal survival model to a uni-
variate mixed model and a Cox PH model. However, other survival distributions were
not considered in their sensitivity analysis.
A study by Cole et al.43 applied a parametric likelihood-based approach to han-
dle left-censoring of HIV VL measurements assuming it follows a standard Normal
distribution. They defined the marginal likelihood for participant i and visit j as:
Lij =
[
φ
(
Y ?ij − µij
σ
)]wij(1−dij) [ 1√
2piσ2
exp
(−(Yij − µij)2
2σ2
)]wijdij
where φ is the cumulative distribution function (CDF) of a standard normal random
variable. Detectable VL measurements contribute the second term, while undetected
(censored) VL measurements contribute to the first term in the likelihood.
While there have been studies comparing the fit of various distributions to right-
censored and interval-censored data,45–47 there are no recommendations in the liter-
ature on optimal distributions to use for left-censored data. Recommendations can
help researchers apply more accurate models for this type of censoring, specifically in
HIV related studies where it is a common occurrence.
1.3 Objectives
The objectives of this study are to:
1. review the non-parametric, semi-parametric, and parametric statistical methods
for analyzing survival data in the presence of left censored data, outlined in
Chapter 2.
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2. derive the Proportional Reverse Hazards (PRH) model for a variety of distri-
butions which may be appropriate for left censored data. These include the
Exponential, Log-normal, Inverse Gaussian, Log-logistic, Gompertz-Makeham,
Gamma, Generalized Gamma, Inverse Gamma, Generalized Inverse Gamma,
Weibull, Inverse Weibull, Generalized Inverse Weibull, Modified Weibull, Flex-
ible Weibull, Power Generalized Weibull, and the Marshal-Olkin distributions.
These derivations are outlined in Chapter 3.
3. conduct simulation studies to assess performance of the derived PRH models
and compare these to establish a guideline for which distribution/s would "best"
fit left censored HIV viral load data. Sample sizes and the proportion of cen-
sored observations will be varied for each distribution to simulate different data
conditions. Details of the simulation setup are provided in Chapter 4. Then,
using a bootstrapping technique, determine which distribution under the PRH
model is best suited for analyzing the VL of HIV infected individuals using the
SC eHARS database.
4. apply the selected best performing models to the SC eHARS database to explain
effects of different demographic, social, and treatment factors on patients’ viral
load transition from detectable to undetectable levels.
9
Chapter 2
Methods for Analyzing Left Censored Data
In this chapter, we will review the statistical methods which have been developed to
analyze time to event data with a focus on methods applied to left censored data.
2.1 Non-Parametric Methods
Non-parametric methods use related data to estimate survival rate instead of assum-
ing a distributional shape for the data. The well-known Kaplan-Meier (KM)48 esti-
mator is a non-parametric approach originally developed for handling right-censored
data, which estimates the survivor function, or 1 − F (t), where F (t) is the CDF. It
is defined as
Sˆ(t) =
∏
ti<t
ni − di
ni
where ni is the number of survivors (persons at risk prior to time ti minus the number
of censored observations) and di is the number of deaths at time ti.
The KM method can be used for left censored data in two ways. The first way
involves converting the left censored data to right censored, calculating the survival
probabilities using the KM method, then flipping it back to the original scale.49
The second way deals directly with the left censored data and has been termed
the Reverse Kaplan-Meier (RKM) estimator50, or equivalently, Turnbull’s method,51
which generalizes the KM estimator to include both left and right censoring. The
RKM estimator is calculated similarly to the above formula but with the censoring
indicator reversed, i.e., it estimates the CDF, F (t), rather than 1 − F (t). It can be
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denoted as
Sˆ(t) =
∏
t>ti
ni − di
ni
These KM and RKM estimators are mainly used to describe the survivorship
patterns of a population or compare the survivorship patterns of two populations.
While it may be advantageous not to assume a distributional shape, especially in cases
where the data do not follow a standard distribution, there are many disadvantages.
Note that these methods are descriptive in nature and do not have the ability to
control for time-invariant or time-dependent covariates.
2.2 Semi-Parametric Methods
Semi-parametric methods are termed as such as they have parametric and non-
parametric components. The most common semi-parametric method used in survival
analysis which can account for covariates, is the Cox Proportional Hazards Model,11
denoted as
λ(t) = λ0(t)exiβ
where λ0(t) is the baseline hazard function, xi is the set of covariates, and β are
parameters estimating covariate effects on hazard. This model is classed as semi-
parametric since no assumptions are made on the baseline hazard function (non-
parametric component) but the effect of the covariates on the hazard rate assumes
a parametric form. This is advantageous in settings where the distribution of the
underlying hazard is not known or it is not of interest to know the distribution of the
baseline hazard rate for the research question. In these cases, the risk of incorrectly
specifying the baseline hazard is more detrimental than not knowing the shape of the
hazard function.
Covariate effects are estimated by maximizing the partial likelihood as opposed
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to the likelihood. The partial likelihood function can be written concisely as
PL =
n∏
i=1
[
exiβ∑n
j=1 Yij e
xjβ
]δi
where Yij = 1 if tj ≥ ti; 0 otherwise, and δi is the censoring indicator.
2.3 Parametric Methods
Parametric models involve assuming a specific distribution for the baseline Hazard
Rate (HR). Let T be a non-negative random variable denoting time to some event.
Then the HR of T is the instantaneous rate of the event occurring in the interval
[t, t+ ∆t) given that the event has not yet occurred. It is defined in notation as
λ(t) = lim
∆t→0
P (t ≤ T < t+ ∆t|T ≥ t)
∆t
2.3.1 Parametric Reversed Hazards Model
For left censored data, the Parametric Reversed Hazard (PRH) model,52 which is a
fully parametric model based on the Reversed Hazard Rate (RHR) has been devel-
oped. In the case of analyzing survival data in the presence of left censoring, reversed
hazard rates are more appropriate to use since estimators of hazard rates tend to be
unstable.52 The RHR53 of T is the instantaneous rate of the event occurring in an
infinitesimal time width, ∆t, preceding t, given that the event occurred before time
t. It is defined as
λ(t) = lim
∆t→0
P (t−∆t ≤ T |T ≤ t)
∆t
In terms of the distribution function, F (t), and probability density function, f(t),
this can be written as
λ(t) = f(t)
F (t)
Let X be a p× 1 vector of covariates. We can now define the PRH model by
λ(t|X) = λ0(t)g(β;X)
12
where λ0(t) is the baseline RHR, g(.) is a nonnegative function of X and β (a p× 1
vector of regression parameters). λ(t|X) is the RHR of T given the covariates X.
The PRH model can be expressed in terms of the distribution function as
F (t|X) = F0(t)g(β;X)
where F (t|X) is the distribution function of T given X and F0(t) is the baseline
distribution function in the absence of covariates.
Suppose that the lifetime random variable T is randomly left censored by Z. In
practice, we may observe the vectors (Y, δ,X), where Y = max(T, Z) and δ = I(T =
Y ) with I(.) being the indicator function. The likelihood function can then be written
as
L(β, y) =
n∏
i=1
f(yi|xi)δiF (yi|xi)1−δi
Using the method of maximum likelihood, we can then derive estimates for the
parameters in this model. This general notation can be applied to any distribution
where the specifications of the PRH model is derived for the distributions used in
this study (shown in Chapter 4).
2.4 Bayesian Methods
Bayesian inference starts with the likelihood distribution of the data given the model
parameters, p(Y |θ), and the prior information on the distribution of the model pa-
rameters, p(θ). Then, using Bayes’ Theorem, inference is made based on the posterior
distribution:
p(θ|Y ) = p(Y |θ)p(θ)
p(Y )
= p(Y |θ)p(θ)∫
p(Y |θ)p(θ)dθ
∝ p(Y |θ)p(θ)
13
Using this approach, Huynh et al.54 developed a Bayesian model for analyzing left
censored data. In this model, the censored observations, Yi,cen, are treated as missing
values. The posterior distribution of these censored values, in addition to the model
parameters, θ, are obtained based on the observed data, Yi,obs.
p(θ, Ycen|Yobs) ∝ p(θ) ×
∏
observed
[p(Yi,obs|θ)I(Yi,obs > LODi)]
× ∏
censored
[p(Yi,cen|θ)I(Yi,cen ≤ LODi)]
where p(θ) is the prior distribution, LODi is the limit of detection for each obser-
vation, and I(.) denotes an indicator function which will ensure that each imputed
censored value is not greater than its’ respective limit of detection. This model can
use either the PDF or CDF for the censored values since theoretically they would be
equivalent.54
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Chapter 3
Derivation of Parametric Reversed Hazards
Model
In this chapter, we extend the work done by Variyath and Sankaran52 on developing a
PRH model using an Inverse Weibull distribution. Using the same technique, we will
derive the PRH model for the Exponential, Generalized Exponential, Log-normal,
Inverse Gaussian, Log-logistic, Gompertz-Makeham, Gamma, Generalized Gamma,
Inverse Gamma, Generalized Inverse Gamma, Weibull, Generalized Inverse Weibull,
Modified Weibull, Flexible Weibull, Power Generalized Weibull, and the Marshal-
Olkin distribution.
3.1 Inverse Weibull Distribution
When the lifetime random variable follows an inverted Weibull distribution, the base-
line distribution function is given by
F0(t) = e−γ/t
α
, t > 0;α, γ > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
γα
tα+1
Note that the baseline Reversed Hazard Rate is decreasing as t increases. In the
presence of the covariates X and assuming that g(β;X) = exp(xiβ) (see Section 2.3),
we have the following
λ(t|X) = γα
tα+1
exp(xiβ)
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F (t|X) = e−(γ/tα) exp(xiβ)
f(t|X) = γα exp(xiβ)
tα+1
e−(γ/t
α) exp(xiβ)
From these, the likelihood function for the inverted Weibull is obtained as
L(β, α, γ, y) =
n∏
i=1
[
γα exp(xiβ)
yα+1i
e−(γ/y
α
i ) exp(xiβ)
]δi [
e−(γ/y
α
i ) exp(xiβ)
]1−δi
so that the log likelihood function is
l(β, α, γ, y) =
n∑
i=1
δixiβ +
n∑
i=1
δi(ln γ + lnα)− (α + 1)
n∑
i=1
δi ln yi − γ
n∑
i=1
exp(xiβ)
yαi
3.2 Exponential Distribution
When the lifetime random variable follows an Exponential distribution, the baseline
distribution function is given by
F0(t) = 1− e−t/γ, t > 0; γ > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
e−t/γ
γ(1− e−t/γ)
In the presence of the covariates X, we have the following
λ(t|X) = e
−t/γ
γ(1− e−t/γ) exp(xiβ)
F (t|X) = (1− e−t/γ)exp(xiβ)
f(t|X) = e
−t/γ
γ
exp(xiβ)(1− e−t/γ)exp(xiβ)−1
From these, the likelihood function for the Exponential distribution is obtained as
L(β, γ, t) =
n∏
i=1
[
e−ti/γ
γ
exp(xiβ)(1− e−ti/γ)exp(xiβ)−1
]δi [
(1− e−ti/γ)exp(xiβ)
]1−δi
so that the log likelihood function is
l(β, γ, t) =
n∑
i=1
δixiβ − 1
γ
n∑
i=1
δiti −
n∑
i=1
δi ln γ +
n∑
i=1
(exiβ − δi) ln(1− e−ti/γ)
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3.3 Log-normal Distribution
When the lifetime random variable follows a Log-normal distribution, the baseline
distribution function is given by
F0(t) = Φ
(
ln(t)− µ
σ
)
, t > 0;µ, σ > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
1√
2piσt exp
(
− [ln(t)−µ]22σ2
)
Φ
(
ln(t)−µ
σ
)
In the presence of the covariates X, we have the following
λ(t|X) = exp
(
− [ln(t)−µ]22σ2
)
√
2piσt Φ
(
ln(t)−µ
σ
) exp(xiβ)
F (t|X) =
[
Φ
(
ln(t)− µ
σ
)]exp(xiβ)
f(t|X) = 1√
2piσt
exp
(
− [ln(t)− µ]
2
2σ2 + xiβ
)[
Φ
(
ln(t)− µ
σ
)]exp(xiβ)−1
From these, the likelihood function for the Log-normal distribution is obtained as
L(µ, σ, t) =
n∏
i=1
 1√
2piσt
exp
(
− [ln(t)− µ]
2
2σ2 + xiβ
)[
Φ
(
ln(t)− µ
σ
)]exp(xiβ)−1δi
×
[
Φ
(
ln(t)− µ
σ
)](1−δi) exp(xiβ)
so that the log likelihood function is
l(µ, σ, t) =
n∑
i=1
δixiβ −
n∑
i=1
δi ln(
√
2piσti) +
n∑
i=1
δi
[ln(t)− µ]2
2σ2
+
n∑
i=1
(exiβ − δi) ln
[
Φ
(
ln(t)− µ
σ
)]
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3.4 Inverse Gaussian Distribution
When the lifetime random variable follows a Inverse Gaussian distribution, the base-
line distribution function is given by
F0(t) = Φ
[
−
√
γ
t
(
t
α
− 1
)]
− exp
(2γ
α
)
Φ
[
−
√
γ
t
(
t
α
+ 1
)]
, t > 0;α, γ > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
√
γ
2pit3 exp
[−γ(t−α)2
2α2t
]
Φ
[
−
√
γ
t
(
t
α
− 1
)]
− exp
(
2γ
α
)
Φ
[
−
√
γ
t
(
t
α
+ 1
)]
In the presence of the covariates X, we have the following
λ(t|X) =
√
γ
2pit3 exp
[−γ(t−α)2
2α2t + xiβ
]
Φ
[
−
√
γ
t
(
t
α
− 1
)]
− exp
(
2γ
α
)
Φ
[
−
√
γ
t
(
t
α
+ 1
)]
F (t|X) =
{
Φ
[
−
√
γ
t
(
t
α
− 1
)]
− exp
(2γ
α
)
Φ
[
−
√
γ
t
(
t
α
+ 1
)]}exp(xiβ)
f(t|X) =
√
γ
2pit3 exp
[−γ(t− α)2
2α2t + xiβ
]
×
{
Φ
[
−
√
γ
t
(
t
α
− 1
)]
− exp
(2γ
α
)
Φ
[
−
√
γ
t
(
t
α
+ 1
)]}exp(xiβ)−1
From these, the likelihood function for the Inverse Gaussian distribution is obtained
as
L(α, γ, t) =
n∏
i=1
{√
γ
2pit3i
exp
[−γ(ti − α)2
2α2ti
+ xiβ
]}δi
×
{
Φ
[
−
√
γ
ti
(
ti
α
− 1
)]
− exp
(2γ
α
)
Φ
[
−
√
γ
ti
(
ti
α
+ 1
)]}exp(xiβ)−δi
so that the log likelihood function is
l(α, γ, t) =
n∑
i=1
δixiβ +
1
2
n∑
i=1
δi ln
(
γ
2pit3i
)
−
n∑
i=1
[
δiγ(ti − α)2
2α2ti
]
+
n∑
i=1
[
exiβ − δi
]
ln
{
Φ
[
−
√
γ
ti
(
ti
α
+ 1
)]}
+
n∑
i=1
[
exiβ − δi
]
ln
[
1− exp
(2γ
α
)]
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3.5 Log-logistic Distribution
When the lifetime random variable follows a Log-logistic distribution, the baseline
distribution function is given by
F0(t) =
1
1 +
(
t
α
)−ω , t > 0;α, ω > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
ω
t
1 +
(
t
α
)ω
In the presence of the covariates X, we have the following
λ(t|X) =
ω
t
exp(xiβ)
1 +
(
t
α
)ω
F (t|X) =
 1
1 +
(
t
α
)−ω

exp(xiβ)
f(t|X) =
 ωt exp(xiβ)
1 +
(
t
α
)ω

 1
1 +
(
t
α
)−ω

exp(xiβ)
From these, the likelihood function for the Log-logistic distribution is obtained as
L(α, ω, t) =
n∏
i=1
 ωti exp(xiβ)
1 +
(
ti
α
)ω
δi
 1
1 +
(
ti
α
)−ω

exp(xiβ)
so that the log likelihood function is
l(α, ω, t) =
n∑
i=1
δixiβ +
n∑
i=1
δi ln
(
ω
ti
)
−
n∑
i=1
δi ln
[
1 +
(
ti
α
)ω]
+
n∑
i=1
exiβ ln
[
1 +
(
ti
α
)−ω]
3.6 Gompertz-Makeham Distribution
When the lifetime random variable follows a Gompertz-Makeham distribution, the
baseline distribution function is given by
F0(t) = 1− exp
[
−α
γ
(
eγt − 1
)]
, t > 0;α, γ > 0
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The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
αeγt exp
[
−α
γ
(eγt − 1)
]
1− exp
[
−α
γ
(eγt − 1)
]
In the presence of the covariates X, we have the following
λ(t|X) = αe
γt exp
[
−α
γ
(eγt − 1)
]
exp(xiβ)
1− exp
[
−α
γ
(eγt − 1)
]
F (t|X) =
{
1− exp
[
−α
γ
(
eγt − 1
)]}exp(xiβ)
f(t|X) = αeγt exp
[
−α
γ
(
eγt − 1
)]
exiβ
{
1− exp
[
−α
γ
(
eγt − 1
)]}exp(xiβ)−1
From these, the likelihood function for the Gompertz-Makeham distribution is
obtained as
L(α, γ, t) =
n∏
i=1
{
αeγti exp
[
−α
γ
(
eγti − 1
)]
exiβ
}δi
×
{
1− exp
[
−α
γ
(
eγti − 1
)]}exp(xiβ)−δi
so that the log likelihood function is
l(α, γ, t) =
n∑
i=1
δixiβ +
n∑
i=1
δi lnα +
n∑
i=1
δiγti −
n∑
i=1
δiα
γ
(
eγti − 1
)
+
n∑
i=1
(
exiβ − δi
)
ln
{
1− exp
[
−α
γ
(
eγti − 1
)]}
3.7 Gamma Distribution
When the lifetime random variable follows a Gamma distribution, the baseline dis-
tribution function is given by
F0(t) =
γ(α, ωt)
Γ(α) , t > 0;α, ω > 0
where γ(α, t) is the incomplete Gamma function and Γ(α) is the complete Gamma
function. The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
ωαtα−1e−ωt
γ(α, ωt)
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In the presence of the covariates X, we have the following
λ(t|X) = ω
αtα−1 exp(−ωt+ xiβ)
γ(α, ωt)
F (t|X) =
[
γ(α, ωt)
Γ(α)
]exp(xiβ)
f(t|X) = ω
αtα−1 exp(−ωt+ xiβ)
γ(α, ωt)
[
γ(α, ωt)
Γ(α)
]exp(xiβ)
From these, the likelihood function for the Gamma distribution is obtained as
L(α, ω, t) =
n∏
i=1
[
ωαtα−1i exp(−ωti + xiβ)
γ(α, ωti)
]δi [γ(α, ωti)
Γ(α)
]exp(xiβ)
so that the log likelihood function is
l(α, ω, t) =
n∑
i=1
δixiβ +
n∑
i=1
δiα lnω + (α− 1)
n∑
i=1
δi ln ti −
n∑
i=1
δiωti
+
n∑
i=1
(
exiβ − δi
)
ln [γ(α, ωti)]−
n∑
i=1
exiβ ln [Γ(α)]
Note that the exponential distribution is a special case of this result.
3.8 Generalized Gamma Distribution
When the lifetime random variable follows a Generalized Gamma distribution, the
baseline distribution function is given by
F0(t) =
γ
[
α
ω
, (λt)ω
]
Γ
(
α
ω
) , t > 0;α, ω, λ > 0
where γ(α, t) is the incomplete Gamma function and Γ(α) is the complete Gamma
function. The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
ωλαtα−1e−(λt)
ω
γ
[
α
ω
, (λt)ω
]
In the presence of the covariates X, we have the following
λ(t|X) = ωλ
αtα−1e−(λt)
ω+xiβ
γ
[
α
ω
, (λt)ω
]
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F (t|X) =
γ
[
α
ω
, (λt)ω
]
Γ
(
α
ω
)
exp(xiβ)
f(t|X) = ωλ
αtα−1e−(λt)
ω+xiβ
γ
[
α
ω
, (λt)ω
]
γ
[
α
ω
, (λt)ω
]
Γ
(
α
ω
)
exp(xiβ)
From these, the likelihood function for the Generalized Gamma distribution is
obtained as
L(α, ω, λ, t) =
n∏
i=1
ωλαtα−1i e−(λti)ω+xiβ
γ
[
α
ω
, (λti)ω
]
δi γ
[
α
ω
, (λti)ω
]
Γ
(
α
ω
)
exp(xiβ)
so that the log likelihood function is
l(α, ω, λ, t) =
n∑
i=1
δixiβ +
n∑
i=1
δiα ln(ωλ) + (α− 1)
n∑
i=1
δi ln ti −
n∑
i=1
δi(λti)ω
+
n∑
i=1
(exiβ − δi) ln
[
γ
[
α
ω
, (λti)ω
]]
−
n∑
i=1
exiβ ln
[
Γ
(
α
ω
)]
3.9 Inverse Gamma Distribution
When the lifetime random variable follows a Inverse Gamma distribution, the baseline
distribution function is given by
F0(t) =
γ(α, t)
Γ(α) , t > 0;α, ω > 0
where γ(α, t) is the incomplete Gamma function and Γ(α) is the complete Gamma
function. The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
ωαt−α−1e−ω/t
γ(α, t)
In the presence of the covariates X, we have the following
λ(t|X) = ω
αt−α−1e−ω/t
γ(α, t) exp(xiβ)
F (t|X) =
[
γ(α, t)
Γ(α)
]exp(xiβ)
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f(t|X) = ω
αt−α−1e−ω/t
γ(α, t) exp(xiβ)
[
γ(α, t)
Γ(α)
]exp(xiβ)
From these, the likelihood function for the Inverse Gamma distribution is obtained
as
L(α, ω, t) =
n∏
i=1
[
ωαt−α−1e−ω/t+xiβ
γ(α, t)
]δi [γ(α, t)
Γ(α)
]exp(xiβ)
so that the log likelihood function is
l(α, ω, t) =
n∑
i=1
δixiβ +
n∑
i=1
δiα lnω − (α + 1)
n∑
i=1
δi ln ti −
n∑
i=1
δiω
ti
+
n∑
i=1
(
exiβ − δi
)
ln [γ(α, ti)]−
n∑
i=1
exiβ ln [Γ(α)]
3.10 Weibull Distribution
When the lifetime random variable follows a Weibull distribution, the baseline distri-
bution function is given by
F0(t) = 1− e−(
t
γ )
α
, t > 0;α, γ > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
(
α
γ
) (
t
γ
)α−1
e−(
t
γ )
α
1− e−( tγ )
α
In the presence of the covariates X, we have the following
λ(t|X) =
(
α
γ
) (
t
γ
)α−1
e−(
t
γ )
α+xiβ
1− e−( tγ )
α
F (t|X) =
[
1− e−( tγ )
α
]exp(xiβ)
f(t|X) =
(α
γ
)(
t
γ
)α−1
e−(
t
γ )
α+xiβ
 [1− e−( tγ )α]exp(xiβ)−1
From these, the likelihood function for the Weibull distribution is obtained as
L(α, γ, t) =
n∏
i=1
(α
γ
)(
ti
γ
)α−1
e−(
ti
γ )
α
+xiβ
δi [1− e−( tiγ )α]exp(xiβ)−δi
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so that the log likelihood function is
l(α, γ, t) =
n∑
i=1
δixiβ +
n∑
i=1
δi lnα−
n∑
i=1
δiα ln γ + (α− 1)
n∑
i=1
δi ln ti
−
n∑
i=1
δi
(
ti
γ
)α
+
n∑
i=1
(
exiβ − δi
)
ln
[
1− e−( tγ )
α
]
3.11 Generalized Inverse Weibull Distribution
When the lifetime random variable follows a Generalized Inverse Weibull distribution,
the baseline distribution function is given by
F0(t) = e−γ(
λ
t )
α
, t > 0;α, γ, λ > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) = αγλαt−(α−1)
In the presence of the covariates X, we have the following
λ(t|X) = αγλαt−(α−1)exiβ
F (t|X) =
[
e−γ(
λ
t )
α
]exp(xiβ)
f(t|X) = αγλαt−(α−1)exiβ
[
e−γ(
λ
t )
α
]exp(xiβ)
From these, the likelihood function for the Generalized Inverse Weibull distribu-
tion is obtained as
L(α, γ, λ, t) =
n∏
i=1
[
αγλαt
−(α−1)
i e
xiβ
]δi [
e
−γ
(
λ
ti
)α]exp(xiβ)
so that the log likelihood function is
l(α, γ, λ, t) =
n∑
i=1
δixiβ +
n∑
i=1
δi lnα +
n∑
i=1
δi ln γ +
n∑
i=1
δiα ln λ
−(α− 1)
n∑
i=1
δi ln ti −
n∑
i=1
γ
(
λ
ti
)α
exiβ
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3.12 Modified Weibull Distribution
When the lifetime random variable follows a Modified Weibull distribution55, the
baseline distribution function is given by
F0(t) = 1− exp(−γtαeλt), t > 0;α, γ, λ > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
γ(α + λt)tα−1 exp(λt) exp(−γtαeλt)
1− exp(−γtαeλt)
In the presence of the covariates X, we have the following
λ(t|X) = γ(α + λt)t
α−1 exp(λt) exp(−γtαeλt) exp(xiβ)
1− exp(−γtαeλt)
F (t|X) =
[
1− exp
(
−γtαeλt
)]exp(xiβ)
f(t|X) = γ(α + λt)tα−1 exp(λt) exp(−γtαeλt) exp(xiβ)
[
1− exp(−γtαeλt)
]exp(xiβ)−1
From these, the likelihood function for the Modified Weibull distribution is ob-
tained as
L(α, γ, λ, t) =
n∏
i=1
[
γ(α + λti)tα−1i exp(λti) exp(−γtαi eλti) exp(xiβ)
]δi
×
[
1− exp(−γtαi eλti)
]exp(xiβ)−δi
so that the log likelihood function is
l(α, γ, λ, t) =
n∑
i=1
δixiβ +
n∑
i=1
δi ln γ +
n∑
i=1
δi ln(α + λti) + (α− 1)
n∑
i=1
δi ln ti +
n∑
i=1
δiλti
−
n∑
i=1
δiγt
α
i e
λti +
n∑
i=1
(
exiβ − δi
)
ln
[
1− exp(−γtαi eλti)
]
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3.13 Flexible Weibull Distribution
When the lifetime random variable follows a Flexible Weibull distribution56, the base-
line distribution function is given by
F0(t) = 1− exp
(
−eαt− γt
)
, t > 0;α, γ > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
(
α + γ
t2
)
exp
(
αt− γ
t
)
exp
(
−eαt− γt
)
1− exp
(
−eαt− γt
)
In the presence of the covariates X, we have the following
λ(t|X) =
(
α + γ
t2
)
exp
(
αt− γ
t
)
exp
(
−eαt− γt
)
exp(xiβ)
1− exp
(
−eαt− γt
)
F (t|X) =
[
1− exp
(
−eαt− γt
)]exp(xiβ)
f(t|X) =
(
α + γ
t2
)
exp
(
αt− γ
t
)
exp
(
−eαt− γt
)
exiβ
[
1− exp
(
−eαt− γt
)]exp(xiβ)−1
From these, the likelihood function for the Flexible Weibull distribution is ob-
tained as
L(α, γ, t) =
n∏
i=1
[(
α + γ
t2i
)
exp
(
αti − γ
ti
)
exp
(
−eαti− γti
)
exp(xiβ)
]δi
×
[
1− exp
(
−eαti− γti
)]exp(xiβ)−δi
so that the log likelihood function is
l(α, γ, t) =
n∑
i=1
δixiβ +
n∑
i=1
δi ln
(
α + γ
t2i
)
+
n∑
i=1
δi
(
αti − γ
ti
)
−
n∑
i=1
δie
αti− γti
+
n∑
i=1
(
exiβ − δi
)
ln
[
1− exp
(
−eαti− γti
)]
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3.14 Power Generalized Weibull Distribution
When the lifetime random variable follows a Power Generalized Weibull distribu-
tion57, the baseline distribution function is given by
F0(t) = 1− exp
1− (1 + ( t
λ
)α) 1γ  , t > 0;α, γ, λ > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
α
γλα
tα−1
[
1 +
(
t
λ
)α] 1γ−1 exp [1− (1 + ( t
λ
)α) 1γ ]
1− exp
[
1−
(
1 +
(
t
λ
)α) 1γ ]
In the presence of the covariates X, we have the following
λ(t|X) =
α
γλα
tα−1
[
1 +
(
t
λ
)α] 1γ−1 exp [1− (1 + ( t
λ
)α) 1γ ] exp(xiβ)
1− exp
[
1−
(
1 +
(
t
λ
)α) 1γ ]
F (t|X) =
1− exp
1− (1 + ( t
λ
)α) 1γ 
exp(xiβ)
f(t|X) = α
γλα
tα−1
[
1 +
(
t
λ
)α] 1γ−1
exp
1− (1 + ( t
λ
)α) 1γ  exp(xiβ)
×
1− exp
1− (1 + ( t
λ
)α) 1γ 
exp(xiβ)−1
From these, the likelihood function for the Power Generalized Weibull distribution
is obtained as
L(α, γ, λ, t) =
n∏
i=1
 αγλα tα−1i
[
1 +
(
ti
λ
)α] 1γ−1
exp
1− (1 + (ti
λ
)α) 1γ  exp(xiβ)

δi
×
1− exp
1− (1 + (ti
λ
)α) 1γ 
exp(xiβ)−δi
so that the log likelihood function is
l(α, γ, λ, t) =
n∑
i=1
δixiβ +
n∑
i=1
δi lnα−
n∑
i=1
δi ln γ −
n∑
i=1
δiα ln λ+ (α− 1)
n∑
i=1
δi ln ti
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+
(
1
γ
− 1
)
n∑
i=1
δi ln
[
1 +
(
ti
λ
)α]
+
n∑
i=1
δi
1− (1 + (ti
λ
)α) 1γ 
+
n∑
i=1
(
exiβ − δi
)
ln
1− exp
1− (1 + (ti
λ
)α) 1γ 
3.15 Marshal-Olkin Distribution
When the lifetime random variable follows a Marshal-Olkin distribution58, the base-
line distribution function is given by
F0(t) =
1− e−(λt)α
1− (1− γ)e−(λt)α , t > 0;α, γ, λ > 0
The baseline Reversed Hazard Rate of T is then obtained as
λ0(t) =
γαλ(λt)α−1e−(λt)α
[1− (1− γ)e−(λt)α ] [1− e−(λt)α ]
In the presence of the covariates X, we have the following
λ(t|X) = γαλ(λt)
α−1e−(λt)
α
exiβ
[1− (1− γ)e−(λt)α ] [1− e−(λt)α ]
F (t|X) =
[
1− e−(λt)α
1− (1− γ)e−(λt)α
]exp(xiβ)
f(t|X) = γαλ(λt)
α−1e−(λt)
α
exiβ
[
1− e−(λt)α
]exp(xiβ)−1
[1− (1− γ)e−(λt)α ]exp(xiβ)+1
From these, the likelihood function for the Marshal-Olkin distribution is obtained
as
L(α, γ, λ, t) =
n∏
i=1

γαλ(λti)α−1e−(λti)
α
exiβ
[
1− e−(λti)α
]exp(xiβ)−1
[1− (1− γ)e−(λti)α ]exp(xiβ)+1

δi
×
{
1− e−(λti)α
1− (1− γ)e−(λti)α
}(1−δi) exp(xiβ)
so that the log likelihood function is
l(α, γ, λ, t) =
n∑
i=1
δixiβ +
n∑
i=1
δi ln γ +
n∑
i=1
δi lnα +
n∑
i=1
δiα ln λ+ (α− 1)
n∑
i=1
δi ln ti
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−
n∑
i=1
δi (λti)α +
n∑
i=1
(
exiβ − δi
)
ln
[
1− e−(λti)α
]
−
n∑
i=1
(
exiβ + δi
)
ln
[
1− (1− γ)e−(λti)α
]
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Chapter 4
Simulation Study
In this chapter, we will perform a simulation study to determine if the derived distri-
butions from the previous chapter are adaptable for use in a PRH model and compare
these distributions to establish a guideline for which distribution/s would best fit left
censored HIV VL data.
4.1 Simulation Setup
We generated the simulated data from a Skewed Normal distribution using the sn
package in R as we expected that this would most closely match the left censored
HIV VL data. Different parameters were tested under the Skewed Normal distribu-
tion until the closest matching simulated data could be generated. The final param-
eters chosen were 5 (location), 30 (scale), and 50 (shape) with 100000 observations
randomly generated. The distribution of the simulated data can be seen in Figure
4.1.
From the simulated data, we randomly generated samples of size 1000, 2000, and
3000. The percentage of censored observations was 20, 30, and 40 percent. The
censoring rate was ensured by creating a censoring indicator where 0 represents a
censored observation, 1 otherwise. The indicator was then randomly assigned to the
corresponding proportion of observations. Each of the simulation setups was repeated
5000 times to ensure reliability. To assess which distribution model fits best, we used
4 information criteria:
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Figure 4.1 Distribution of Simulated Data
• Akaike Information Criterion (AIC) rewards goodness of fit but penalizes the
model for increasing the number of estimated parameters.
AIC = 2k − 2 ln(L)
• Corrected Akaike Information Criterion (AICC) corrects the AIC for overfitting
of the data in cases where the sample size is relatively small compared to the
number of parameters in the model.
AICC = AIC + 2k(k + 1)
n− k − 1
• Hannan-Quinn Information Criterion (HQIC) is often cited in the literature
but, unlike AIC, it is not asymptotically efficient.
HQIC = 2k ln(ln(n))− 2 ln(L)
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• Bozdogan’s Consistent Akaike Information Criterion (CAIC) is another ad-
justed form of AIC which is consistent.
CAIC = k(ln(n) + 1)− 2 ln(L)
where k is the number of parameters to be estimated, L is the maximum value of the
likelihood function, and n is the number of observations. The model with the smallest
average AIC, AICC, HQIC, and CAIC value was determined to be the model with
the best fit. This simulation study was conducted using the Statistical Computing
Software, R version 3.2.559 with summary results presented in the following section.
4.2 Simulation Results
Results of the simulation study are summarized in Tables 4.1-4.3. Table 4.1 summa-
rizes the results for the simulated data with a censoring rate of 20%, Table 4.2 for data
with censoring rate of 30%, and Table 4.3 for data with censoring rate 40%. From
these tables, it is clear that the Generalized Inverse Weibull distribution performs
the best, having the lowest average AIC, AICC, HQIC, and CAIC values. Following
closely behind in performance are the Log-Logistic, Log-Normal, Inverse Gaussian,
and Gamma distributions, respectively. This is consistent across all censoring rates
and sample sizes. The consistently worst performing distributions are the Modified
Weibull, Inverse Weibull, Inverse Gamma, Power Generalized Weibull, and Exponen-
tial distributions, respectively.
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Table 4.1 Average summary measures across 5000 simulations from simulation study with censoring rate 20%
Sample Sizes
Distribution 1000 2000 3000
AIC AICC HQIC CAIC AIC AICC HQIC CAIC AIC AICC HQIC CAIC
Exponential 8753.05 8753.06 8754.92 8758.96 17504.19 17504.20 17506.25 17510.79 26255.36 26255.36 26257.52 26262.37
Log-Normal 6162.11 6162.12 6165.84 6173.92 12323.86 12323.87 12327.97 12337.06 18485.63 18485.64 18489.96 18499.65
Inverse Gaussian 6163.50 6163.51 6167.23 6175.31 12326.67 12326.68 12330.79 12339.88 18489.88 18489.89 18494.20 18503.90
Gamma 6199.30 6199.31 6203.03 6211.12 12398.14 12398.14 12402.25 12411.34 18597.16 18597.16 18601.48 18611.17
Generalized Gamma 6206.54 6206.57 6212.14 6224.27 12410.79 12410.80 12416.96 12430.60 18615.33 18615.34 18621.82 18636.35
Inverse Gamma 10622.02 10622.03 10625.75 10633.83 21240.12 21240.13 21244.24 21253.32 31858.19 31858.19 31862.51 31872.20
Log-Logistic 6115.87 6115.88 6119.60 6127.68 12230.91 12230.92 12235.03 12244.12 18346.09 18346.09 18350.41 18360.10
Weibull 6502.31 6502.32 6506.04 6514.13 13007.93 13007.94 13012.05 13021.14 19515.02 19515.03 19519.34 19529.04
Inverse Weibull 13992.74 13992.75 13996.47 14004.55 27981.55 27981.56 27985.66 27994.75 41970.35 41970.35 41974.67 41984.36
Generalized Inverse Weibull 5959.85 5959.87 5965.44 5977.57 11916.55 11916.56 11922.72 11936.35 17873.49 17873.50 17879.97 17894.51
Flexible Weibull 7768.04 7768.05 7771.77 7779.86 15488.38 15488.39 15492.50 15501.59 23311.80 23311.80 23316.12 23325.81
Marshal-Olkin 7532.91 7532.94 7538.51 7550.63 15059.88 15059.90 15066.05 15079.69 22586.86 22586.87 22593.34 22607.88
Power Generalized Weibull 10492.37 10492.38 10496.10 10504.19 20980.81 20980.82 20984.92 20994.01 31469.28 31469.28 31473.60 31483.29
Modified Weibull 2.97e63 2.97e63 2.97e63 2.97e63 1.27e68 1.27e68 1.27e68 1.27e68 1.00e68 1.00e68 1.00e68 1.00e68
Gompertz 8177.79 8177.80 8181.52 8189.60 16177.93 16177.94 16182.05 16191.13 24099.00 24099.01 24103.32 24113.01
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Table 4.2 Average summary measures across 5000 simulations from simulation study with censoring rate 30%
Sample Sizes
Distribution 1000 2000 3000
AIC AICC HQIC CAIC AIC AICC HQIC CAIC AIC AICC HQIC CAIC
Exponential 7752.73 7752.74 7754.60 7758.64 15503.37 15503.37 15505.43 15509.97 23254.14 23254.14 23256.30 23261.15
Log-Normal 5571.09 5571.10 5574.82 5582.91 11141.41 11141.41 11145.52 11154.61 16711.43 16711.43 16715.75 16725.44
Inverse Gaussian 5572.56 5572.57 5576.29 5584.38 11144.38 11144.39 11148.49 11157.58 16715.90 16715.90 16720.22 16729.91
Gamma 5603.77 5603.78 5607.50 5615.58 11206.68 11206.68 11210.79 11219.88 16809.04 16809.04 16813.36 16823.05
Generalized Gamma 5611.47 5611.50 5617.07 5629.20 11219.82 11219.84 11225.99 11239.63 16828.00 16828.01 16834.48 16849.02
Inverse Gamma 9731.22 9731.23 9734.95 9743.04 19458.34 19458.34 19462.45 19471.54 29185.65 29185.66 29189.97 29199.67
Log-Logistic 5521.91 5521.92 5525.64 5533.73 11042.28 11042.28 11046.39 11055.48 16562.88 16562.88 16567.20 16576.89
Weibull 5848.74 5848.75 5852.47 5860.55 11700.72 11700.73 11704.83 11713.92 17551.99 17552.00 17556.31 17566.01
Inverse Weibull 12430.99 12431.01 12434.72 12442.81 24857.86 24857.87 24861.98 24871.07 37284.93 37284.94 37289.25 37298.95
Generalized Inverse Weibull 5401.80 5401.83 5407.40 5419.53 10799.21 10799.22 10805.38 10819.01 16197.20 16197.20 16203.68 16218.22
Flexible Weibull 6843.80 6843.81 6847.53 6855.61 13628.37 13628.37 13632.48 13641.57 20402.93 20402.93 20407.25 20416.94
Marshal-Olkin 7118.74 7118.77 7124.34 7136.47 14231.37 14231.38 14237.54 14251.17 21344.14 21344.15 21350.62 21365.16
Power Generalized Weibull 9251.89 9251.90 9255.62 9263.70 18499.64 18499.64 18503.75 18512.84 27747.57 27747.58 27751.89 27761.59
Modified Weibull 6.15e63 6.15e63 6.15e63 6.15e63 1.95e63 1.95e63 1.95e63 1.95e63 5.20e64 5.20e64 5.20e64 5.20e64
Gompertz 7117.94 7117.95 7121.67 7129.76 14424.68 14424.68 14428.79 14437.88 21422.25 21422.25 21426.57 21436.26
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Table 4.3 Average summary measures across 5000 simulations from simulation study with censoring rate 40%
Sample Sizes
Distribution 1000 2000 3000
AIC AICC HQIC CAIC AIC AICC HQIC CAIC AIC AICC HQIC CAIC
Exponential 6741.30 6741.31 6743.17 6747.21 13480.48 13480.48 13482.54 13487.08 20220.29 20220.29 20222.45 20227.30
Log-Normal 4953.90 4953.91 4957.63 4965.71 9905.84 9905.85 9909.95 9919.04 14861.39 14861.39 14865.71 14875.40
Inverse Gaussian 4955.39 4955.40 4959.12 4967.20 9908.88 9908.88 9912.99 9922.08 14865.96 14865.97 14870.29 14879.98
Gamma 4982.80 4982.82 4986.53 4994.62 9964.45 9964.46 9968.56 9977.65 14948.26 14948.26 14952.58 14962.27
Generalized Gamma 4986.95 4986.98 4992.55 5004.68 9972.46 9972.47 9978.63 9992.26 14961.84 14961.85 14968.33 14982.86
Inverse Gamma 8650.96 8650.97 8654.69 8662.77 17297.85 17297.85 17301.96 17311.05 25945.08 25945.09 25949.41 25959.10
Log-Logistic 4905.78 4905.79 4909.51 4917.59 9809.98 9809.99 9814.09 9823.18 14716.61 14716.62 14720.93 14730.62
Weibull 5174.16 5174.17 5177.89 5185.97 10349.18 10349.19 10353.29 10362.38 15527.55 15527.55 15531.87 15541.56
Inverse Weibull 10840.67 10840.68 10844.40 10852.48 21677.25 21677.26 21681.37 21690.46 32514.24 32514.24 32518.56 32528.25
Generalized Inverse Weibull 4815.45 4815.48 4821.05 4833.18 9626.12 9626.13 9632.29 9645.92 14440.87 14440.88 14447.35 14461.89
Flexible Weibull 5926.41 5926.42 5930.14 5938.23 11890.95 11890.96 11895.07 11904.15 17877.73 17877.73 17882.05 17891.74
Marshal-Olkin 6704.64 6704.66 6710.23 6722.36 13403.17 13403.18 13409.34 13422.97 20102.14 20102.15 20108.62 20123.16
Power Generalized Weibull 8003.90 8003.91 8007.63 8015.72 16003.69 16003.69 16007.80 16016.89 24003.98 24003.98 24008.31 24018.00
Modified Weibull 4.60e63 4.60e63 4.60e63 4.60e63 2.09e62 2.09e62 2.09e62 2.09e62 9.34e65 9.34e65 9.34e65 9.34e65
Gompertz 6218.98 6218.99 6222.71 6230.79 12435.16 12435.17 12439.27 12448.36 18726.64 18726.65 18730.97 18740.66
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Chapter 5
Real Data Application: SC eHARS Database
In this chapter, we apply the PRH model to the South Carolina Enhanced HIV/AIDS
Reporting Surveillance System (SC eHARS) database using the distribution which
was found to be the best fit from our simulation study.
5.1 Background
Since January 2004, all health care providers, hospitals, and laboratories are legally
mandated to report all CD4 count and VL measurements to the SC Department of
Health and Environmental Control (DHEC).60 This data is stored in the SC eHARS
database along with the patient’s socio-demographic characteristics. The quality
rating of the SC eHARS database exceeds the CDC minimum standards of reporting
timeliness with 95% of new cases being reported within 6 months of HIV diagnosis
and 98% of all HIV cases reported.61 Our sample was reduced based on the following
selection criteria (summarized in Figure 5.1):
• aged ≥ 13 years or older
• diagnosed or living with HIV infection between January 1, 2005 and December
31, 2013
• having detectable VL at the start of the study period
• had at least two reported VL values during the study period
36
Initial Sample, N=18,618
Patients who met selec-
tion criteria, N=13,134
Patients who started with
detectable viral load, N=9,242
Patients where event occurred
or are left censored, N=7,972
Patients who did not have 0 or
missing CD4 count, N=6,221
Patients who did not have miss-
ing drug information, N=3,293
Figure 5.1 Flowchart of analytic sample selection procedure and exclusion criteria
The aim of applying the PRH model to this dataset is to explain the risk behavior
of transitioning from detectable VL to undetectable VL. Patients with undetectable
VL at the beginning of the study were defined as being left censored. Covariates that
were assessed include gender (male or female), race (White, Black, or other), HIV
risk exposure group (heterosexual, men who have sex with men, or other), place of
residence (rural or urban), age at baseline, initial treatment regimen (single tablet
regimen, multiple tablet regimen, or neither), and baseline log CD4 count. Note that
HIV risk exposure group refers to how the patient was first exposed to HIV with
options including heterosexual HIV infected partner, men who have sex with other
men, injecting drug user, no identifiable risk, and no risk reported. Results from the
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Table 5.1 Characteristics of persons living with HIV in South Carolina, 2005-2013
Characteristics Frequency (%)/Summary statistics
Gender
Female 2564 (41.22%)
Male 3657 (58.78%)
Race
Black 4966 (79.83%)
White 1086 (17.46%)
Others 169 (2.72%)
Risk of Exposure
Heterosexual 2295 (36.89%)
Men who have Sex with Men (MSM) 1911 (30.72%)
Others 2015 (32.39%)
Place of Residence
Urban 4208 (67.64%)
Rural 2013 (32.36%)
Starting Treatment Regimen
Single Tablet Regimen (STR) 1056 (16.97%)
Multiple Tablet Regimen (MTR) 2237 (35.96%)
N/A 2928 (47.07%)
Baseline Age (in years) Range = 14.84-81.58; Mean = 39.99; SD = 11.46
Log Baseline CD4 Count (cell/mm3) Range = 0.00-3.56; Mean = 2.34; SD = 0.57
Outcome
Event (Det VL to Undet VL) 4518 (72.62%)
Left censored 1703 (27.38%)
Abbreviations: SD = standard deviation; Det = detectable; VL = viral load; Undet = unde-
tectable.
PRH model are presented and discussed in the next section.
Of the individuals in our sample, 1703 (27%) were classified as being left censored
(Table 5.1). Mean age of the sample at baseline was 40.0 years (range = 14.8 - 81.6).
The majority of subjects were male (n=3657, 58.8%), Black (n=4966, 79.8%), and
lived in an urban county when diagnosed with HIV (n=4208, 67.6%). The mean
log CD4 count at the beginning of the study was 2.34 cells/mm3 (range = 0.00 -
3.56 cells/mm3). Almost half of the sample had missing drug information (n=2928,
47.1%).
Comparing the SC eHARS database and the simulated data, you can see that they
match up well on the left tail (Figure 5.2). However, the right tail of the simulated
data is heavier than the right tail of the observed data. This may be a reason for
concern when selecting the best model from the simulation study which led to us to
conduct a bootstrap study. We used a bootstrapping sampling technique to generate
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samples of size 1000, 2000, and 3000 from the observed data i.e. the SC eHARS
database. We used 5000 bootstraps for each setup. Results of this are provided in
the following section.
Figure 5.2 Observed vs Simulated Data
5.2 Results and Discussion
Table 5.2 presents the results from the bootstrap study. From this study, the best per-
forming distributions were found to be the Marshal-Olkin, Modified Weibull, General-
ized Gamma, Gamma, and Flexible Weibull distribution, respectively. This conflicts
with the results from the simulation study, and it’s most likely that this discrepancy is
due to the heavy tail nature of the simulation study data as compared to the observed
data from the SC eHARS database.
Both the Generalized Inverse Weibull and Marshal-Olkin distributions are applied
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to the SC eHARS database. Table 5.3 shows the results of the estimated reverse haz-
ard model using a Generalized Inverse Weibull distribution for persons living with
HIV and Table 5.4 shows the results using the Marshal-Olkin distribution. Informa-
tion on treatment regimen is a very important variable to use in our model. However,
this information is missing in almost 50% of the subjects in our sample. Thus we fit
the model without this variable first (Model 1) and then we fit a second model with
reduced sample size after including the treatment variable in model (Model 2). It
should be noted that if there was not such a large proportion of missing values in the
treatment variable, we would fit only one model, Model 2.
While several covariates have been shown to have an effect on the time from
detectable to undetectable VL level, the significant change in behavior of some of
these covariates comparing the model incorporating the treatment variable compared
to the model without this important factor suggests that an interaction may be
present. Note that Models 1 and 2 cannot be compared using AIC, AICC, HQIC,
and CAIC due to the large difference in sample size. Additional models were run
testing interactions between drug regimen and each of the other covariates. The only
significant interaction found was between drug regimen and age, the results of which
are shown in Table 5.5.
Comparing the two models in Table 5.5, we can see that the Generalized Inverse
Weibull based PRH model fits the data better than the Marshal-Olkin based PRH
model in terms of the information criteria. Hence, the best model applied to the
SC eHARS database is the Generalized Inverse Weibull based PRH model with all
covariates including an interaction of drug regimen and age. Note here how estimates
of the reversed hazard rate and significance differs in these two models, particularly
the interaction between drug and age which changes in direction and maintains sig-
nificance leading to opposing conclusions. This reflects the importance of selecting
the appropriate distribution in a parametric model to analyze left censored data.
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Table 5.2 Average summary measures from bootstrap study
Sample Sizes
Distribution 1000 2000 3000
AIC AICC HQIC CAIC AIC AICC HQIC CAIC AIC AICC HQIC CAIC
Exponential 9873.81 9873.82 9875.68 9879.72 19744.94 19744.94 19747.00 19751.54 29608.05 29608.05 29610.21 29615.06
Log-Normal 8309.58 8309.59 8313.31 8321.39 16613.97 16613.98 16618.09 16627.17 24922.77 24922.77 24927.09 24936.78
Inverse Gaussian 10452.75 10452.76 10456.48 10464.56 20899.89 20899.90 20904.01 20913.10 31353.79 31353.79 31358.11 31367.80
Gamma 7592.29 7592.30 7596.02 7604.11 15179.62 15179.63 15183.73 15192.82 22770.88 22770.88 22775.20 22784.89
Generalized Gamma 7475.02 7475.04 7480.62 7492.74 14944.71 14944.73 14950.88 14964.52 22418.40 22418.40 22424.88 22439.41
Log-Logistic 8309.85 8309.87 8313.59 8321.67 16614.53 16614.54 16618.64 16627.73 24922.87 24955.87 24927.19 24936.88
Weibull 7919.79 7919.80 7923.52 7931.60 15834.46 15834.46 15838.57 15847.66 23752.54 23752.54 23756.86 23766.55
Inverse Weibull 8857.13 8857.14 8860.86 8868.94 17708.94 17708.94 17713.05 17722.14 26570.04 26570.04 26574.36 26584.05
Generalized Inverse Weibull 8657.62 8657.64 8663.22 8675.34 17308.05 17308.06 17314.22 17327.85 25963.86 25963.87 25970.34 25984.88
Flexible Weibull 7772.01 7772.02 7775.74 7783.83 15541.72 15541.72 15545.83 15554.92 23319.71 23319.71 23324.03 23333.72
Marshal-Olkin 5029.27 5029.29 5034.87 5046.99 10051.39 10051.40 10057.56 10071.19 15068.73 15068.73 15075.21 15089.74
Power Generalized Weibull 7998.86 7998.87 8002.59 8010.67 15992.53 15992.53 15996.64 16005.73 23990.21 23990.21 23994.53 24004.22
Modified Weibull 7372.54 7372.56 7378.13 7390.26 14741.53 14741.54 14747.69 14761.33 22115.79 22115.80 22122.27 22136.81
Gompertz 9869.09 9869.10 9872.82 9880.90 19742.41 19742.42 19746.53 19755.62 29601.23 29601.24 29605.56 29615.25
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Table 5.3 Estimated Reverse Hazard Rates (HR) using Generalized Inverse Weibull
Reverse Hazard model of SC adult HIV patients
Characteristics Model 1 Model 2
Reverse HR (95% CI) Reverse HR (95% CI)
Drug Regimen
Single Tablet Regimen (STR) — Ref
Multiple Tablet Regimen (MTR) — 1.56 (1.37, 1.77)
Gender
Female Ref Ref
Male 0.81 (0.75, 0.87) 1.11 (0.99, 1.25)
Race
Black Ref Ref
White 0.60 (0.55, 0.66) 1.44 (1.30, 1.59)
Others 3.60 (3.26, 4.00) 1.64 (1.29, 2.08)
Risk of Exposure
Heterosexual Ref Ref
Men who have Sex with Men (MSM) 2.08 (1.88, 2.32) 1.73 (1.52, 1.97)
Others 1.96 (1.81, 2.14) 1.20 (1.07, 1.34)
Place of Residence
Rural Ref Ref
Urban 2.35 (2.16, 2.56) 0.47 (0.43, 0.51)
Baseline Age (in years) 1.02 (1.01, 1.03) 1.03 (1.03, 1.04)
Log Baseline CD4 Count(cell/mm3) 0.30 (0.29, 0.31) 0.37 (0.35, 0.39)
AIC 56332.53 31807.20
AICC 56332.57 31807.29
HQIC 56358.21 31833.40
CAIC 56417.62 31892.39
Table 5.4 Estimated Reverse Hazard Rates (HR) using Marshal-Olkin Reverse Hazard
model of SC adult HIV patients
Characteristics Model 1 Model 2
Reverse HR (95% CI) Reverse HR (95% CI)
Drug Regimen
Single Tablet Regimen (STR) — Ref
Multiple Tablet Regimen (MTR) — 1.00 (0.91, 1.10)
Gender
Female Ref Ref
Male 0.72 (0.67, 0.78) 1.17 (1.05, 1.30)
Race
Black Ref Ref
White 2.32 (2.16, 2.49) 1.21 (1.09, 1.34)
Others 1.23 (1.03, 1.48) 0.94 (0.74, 1.21)
Risk of Exposure
Heterosexual Ref Ref
Men who have Sex with Men (MSM) 0.75 (0.67, 0.84) 0.98 (0.86, 1.11)
Others 1.67 (1.55, 1.80) 1.32 (1.19, 1.46)
Place of Residence
Rural Ref Ref
Urban 1.22 (1.14, 1.31) 1.01 (0.93, 1.11)
Baseline Age (in years) 1.04 (1.04, 1.04) 1.02 (1.02, 1.03)
Log Baseline CD4 Count(cell/mm3) 0.81 (0.79, 0.84) 0.93 (0.88, 0.97)
AIC 46170.84 25552.72
AICC 46170.88 25552.82
HQIC 46196.52 25578.92
CAIC 46255.93 25637.92
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Table 5.5 Estimated Reverse Hazard Rates using Generalized Inverse Weibull and
Marshal-Olkin Reverse Hazard model of SC adult HIV patients
Characteristics Generalized Inverse Weibull Marshal-Olkin
Reverse HR (95% CI) Reverse HR (95% CI)
Drug Regimen
Single Tablet Regimen (STR) Ref Ref
Multiple Tablet Regimen (MTR) 0.88 (0.70, 1.10) 0.89 (0.62, 1.29)
Gender
Female Ref Ref
Male 1.35 (1.23, 1.47) 0.86 (0.73, 1.01)
Race
Black Ref Ref
White 1.25 (1.16, 1.34) 1.04 (0.87, 1.24)
Others 0.40 (0.29, 0.55) 1.01 (0.70, 1.44)
Risk of Exposure
Heterosexual Ref Ref
Men who have Sex with Men (MSM) 1.28 (1.16, 1.42) 0.90 (0.72, 1.12)
Others 1.37 (1.26, 1.49) 1.39 (1.19, 1.63)
Place of Residence
Rural Ref Ref
Urban 1.11 (1.04, 1.19) 1.20 (1.04, 1.39)
Baseline Age (in years) 0.99 (0.99, 1.00) 0.91 (0.88, 0.94)
Log Baseline CD4 Count(cell/mm3) 0.88 (0.81, 0.95) 0.96 (0.88, 1.06)
Interaction of drug by age 0.97 (0.97, 0.98) 1.14 (1.10, 1.18)
AIC 35038.08 37409.31
AICC 35038.19 37409.43
HQIC 35066.47 37437.70
CAIC 35130.38 37501.61
From this final model, we can make the following conclusions on the behavior of
transitioning from detectable VL to undetectable VL level. Males are more likely to
reach undetectable levels faster than females (RHR:1.35; CI:1.23, 1.47). This trend
is also evident in several recent studies62,63. A possible reason for this disparity may
be higher rates of treatment adherence among males compared to females. Though
some studies did not find an association between gender and treatment adherence,
a meta-analysis64 of 207 studies concluded that males adhere more to ART than
females.
Individuals who classify as White are more likely to reach undetectable levels
faster than Black individuals (RHR:1.25; CI:1.16, 1.34). This is supported by previ-
ous studies which highlight that Black individuals are disproportionately affected
by HIV/AIDS as they tend to have poorer access to health care, are less likely
to receive treatment, less likely to adhere to treatment, and less likely to survive
HIV/AIDS.62,65–67
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People with high risk of exposure such as men who have sex with men (RHR:1.28;
CI:1.16, 1.42) and other high risk groups (RHR:1.37; CI:1.26, 1.49) are more likely to
reach undetectable levels faster than heterosexual men. It is unclear why this trend
is evident in higher risk groups but another study has shown similar results.60
People who live in urban areas are more likely to reach undetectable levels faster
than those who live in rural areas at the time of diagnosis (RHR:1.11; CI:1.04, 1.19).
A possible reason for this effect may be due to the typically increased access to health
care and higher range of specialists available to people living with HIV/AIDS in urban
areas. This is supported by a study which does an in depth analysis on the effect of
place of residence on the timing of diagnosis and stage of disease at diagnosis.61
Individuals with higher CD4 count at baseline are less likely to reach undetectable
levels faster than those with lower levels of log CD4 count (RHR:0.88; CI:0.81, 0.95).
The literature on the association between changes in viral load and CD4 is inconclu-
sive. Some studies68 support our finding, while others highlight an opposing trend69.
It has been suggested that those with higher CD4 count may be less adherent due to
the absence of symptoms and hence patients do not complete the treatment regimen
as they feel better.
Finally, the interaction between drug regimen and age highlights that older people
who are on a multiple treatment regimen are likely to reach undetectable levels slower
than their younger counterparts (RHR:0.97; CI:0.97, 0.98). There are mixed findings
on this is the literature. Young people with HIV tend to have delayed diagnosis and
thus higher VL at baseline. One study [60] suggests that this along with underuti-
lization of health care due to HIV-related stigma explains their finding that younger
people with HIV reach undetectable levels slower than their older counterparts. A
possible explanation of our result may be that older people are not as adherent to
treatment [64] or perhaps they have a co-existing morbidity which effects the rate at
which they reach undetectable levels.
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Chapter 6
Conclusions
The current study derived several extensions of the PRH model and conducted ex-
tensive simulation studies to evaluate the usefulness of parametric regression models
based on the reversed hazard rate for analyzing left censored HIV viral load data.
Simulation studies suggests the best distribution to use under the PRH model is the
Generalized Inverse Weibull distribution with the Log-Logistic, Log-Normal, Inverse
Gaussian, and Gamma distribution following next in ranking of performance, respec-
tively. The bootstrap analysis suggested the Marshal-Olkin distribution to be the
superior performer with the Modified Weibull, Generalized Gamma, Gamma, and
Flexible Weibull distributions following behind. Although the bootstrap study was
conducted to support the guidelines established in the simulation study, our results
are inconsistent. This disagreement may be a result of the characteristic heavy tail
nature of VL data that requires further attention and more research. However, when
both the top performers of the simulation study and the boostrap study are applied
to the SC eHARS database, the Generalized Inverse Weibull based PRH model out-
performs the Marshal-Olkin based PRH model. Application of this best performing
model on the SC eHARS data revealed important factors on the time to transition
from detectable to undetectable viral load levels.
There are several limitations of the SC eHARS database. One limitation is that
almost 50% of drug related information is missing which creates complications in
estimating hazard rates. Future research using this data should attempt to account
for this missingness to make meaningful conclusions on the population. Data on VL
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and CD4 count measurements were not available for those who dropped out of medical
care after initial diagnosis - this includes those who passed away, moved to a different
state, etc. Additionally, persons living with HIV/AIDS who have not been diagnosed
were not captured in this database. The database also does not include information on
morbidities which may be co-existing with HIV/AIDS which can impact the effect of
drug regimens, especially in older people. Since the interaction between age and drug
regimen is significant, co-existing conditions warrant further exploration. Regardless
of these limitations, the application to the SC eHARS database provides important
information on the trajectories of viral load in SC over time.
In conclusion, we recommend that the Generalized Inverse Weibull PRH model
be used for analyses involving skewed, heavy tailed left censored HIV VL data.
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